US Patent Issued to BIOVERATIV THERAPEUTICS on Oct. 27 for "Optimized factor VIII genes" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,319, issued on Oct. 27, was assigned to BIOVERATIV THERAPEUTICS INC. (Waltham, Mass.).

"Optimized factor VIII genes" was invented by Ajay Maghodia (Waltham, Mass.), Tongyao Liu (Waltham, Mass.) and Philip Zakas (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides codon optimized Factor VIII sequences, vectors, and host cells comprising codon optimized Factor VIII sequences, polypeptides encoded by codon optimized Factor VIII sequences, and methods of producing such polypeptides."

The patent was filed on Aug. 22, 2022, under Application No. 17/821,359.

*For further information, including images, charts and ...